With $NVAX funding, the U.S. government has now committed nearly $4 billion toward vaccine development: 

$JNJ - $456 million
$SNY - $30 million
$MRK (via IAVI) - $38 million
$MRNA - $536 million
$AZN - $1.2 billion
$NVAX - $1.6 billion

https://t.co/ykWXuqBYaM